Friday, January 11, 2019

Rafael Holdings (RFL) Granted Orphan Drug Designation from EMA for Devimistat (CPI-613) for Treatment of Metastatic Pancreatic Cancer - https://t.co/gM21sWkdr3 https://t.co/1qlzSXMKJD


from Twitter https://twitter.com/IDROOhio

January 10, 2019 at 10:01PM
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)